A comprehensive view of Sanofi SA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron and Sanofi announce European Medicines Agency recommends approval of Dupixent injectable in the EU to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy; final decision expected in coming months

Biogen picks Christopher Viehbacher, former leader of Sanofi, as new CEO to replace Michel Vounatsos, who is stepping down from the job; Viehbacher previously headed healthcare investment fund Gurnet Point Capital

AI-driven drug discovery firm Insilico Medicine signs strategic collaboration with Sanofi worth up to US$1.2B; partnership will leverage Insilico’s Pharma.AI AI platform to advance drug development candidates for up to six new targets

AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Sanofi, Samsung Biologics partner to reduce emissions in the pharmaceutical supply chain; group operating through the UN’s Sustainable Markets Initiative Health systems task force

European Medicines Agency approves Sanofi and AstraZeneca’s Beyfortus nirsevimab single-dose vaccine to prevent RSV lower respiratory tract disease in infants; in 2019 there were an estimated 33 million RSV infections worldwide

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count